BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7557191)

  • 21. Photodynamic therapy for Barrett's esophagus: a review.
    Kelty CJ; Marcus SL; Ackroyd R
    Dis Esophagus; 2002; 15(2):137-44. PubMed ID: 12220421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Photodynamic therapy of early squamous cell carcinomas of the esophagus: a review of 31 cases.
    Savary JF; Grosjean P; Monnier P; Fontolliet C; Wagnieres G; Braichotte D; van den Bergh H
    Endoscopy; 1998 Mar; 30(3):258-65. PubMed ID: 9615874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimization of light dosimetry for photodynamic therapy of Barrett's esophagus: efficacy vs. incidence of stricture after treatment.
    Panjehpour M; Overholt BF; Phan MN; Haydek JM
    Gastrointest Endosc; 2005 Jan; 61(1):13-8. PubMed ID: 15672050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long term efficacy of Photodynamic Therapy (PDT) as an ablative therapy of high grade dysplasia in Barrett's oesophagus.
    Gray J; Fullarton GM
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):561-5. PubMed ID: 24284112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in esophageal motility after porfimer sodium photodynamic therapy for Barrett's dysplasia and mucosal carcinoma.
    Shah AK; Wolfsen HC; Hemminger LL; Shah AA; DeVault KR
    Dis Esophagus; 2006; 19(5):335-9. PubMed ID: 16984528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Photodynamic therapy (PDT) in Barrett's esophagus with dysplasia or early cancer.
    Foroulis CN; Thorpe JA
    Eur J Cardiothorac Surg; 2006 Jan; 29(1):30-4. PubMed ID: 16337389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5-Aminolaevulinic acid-induced photodynamic therapy and photodetection in Barrett's esophagus.
    Claydon PE; Ackroyd R
    Dis Esophagus; 2004; 17(3):205-12. PubMed ID: 15361092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pilot study on light dosimetry variables for photodynamic therapy of Barrett's esophagus with high-grade dysplasia.
    Gill KR; Wolfsen HC; Preyer NW; Scott MV; Gross SA; Wallace MB; Jones LR
    Clin Cancer Res; 2009 Mar; 15(5):1830-6. PubMed ID: 19240171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new long-range through-the-scope balloon applicator for photodynamic therapy in the esophagus and cardia.
    Gossner L; May A; Sroka R; Ell C
    Endoscopy; 1999 Jun; 31(5):370-6. PubMed ID: 10433046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Porfimer sodium photodynamic therapy for management of Barrett's esophagus with high-grade dysplasia.
    Panjehpour M; Overholt BF
    Lasers Surg Med; 2006 Jun; 38(5):390-5. PubMed ID: 16788927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Photosensitization with hematoporphyrin derivative compared to 5-aminolaevulinic acid for photodynamic therapy of esophageal carcinoma.
    Maier A; Tomaselli F; Matzi V; Rehak P; Pinter H; Smolle-Jüttner FM
    Ann Thorac Surg; 2001 Oct; 72(4):1136-40. PubMed ID: 11603425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Photodynamic therapy for treatment of early adenocarcinoma in Barrett's esophagus.
    Overholt B; Panjehpour M; Tefftellar E; Rose M
    Gastrointest Endosc; 1993; 39(1):73-6. PubMed ID: 8454152
    [No Abstract]   [Full Text] [Related]  

  • 33. Photodynamic therapy for the treatment of patients with Barrett's high-grade dysplasia and mucosal adenocarcinoma.
    Triadafilopoulos G
    Nat Clin Pract Gastroenterol Hepatol; 2005 Mar; 2(3):136-7. PubMed ID: 16265153
    [No Abstract]   [Full Text] [Related]  

  • 34. Barrett's esophagus: treatment with 5-aminolevulinic acid photodynamic therapy.
    Barr H
    Gastrointest Endosc Clin N Am; 2000 Jul; 10(3):421-37. PubMed ID: 10899256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Barrett's esophagus seen in new photodynamic light.
    Morrow T
    Manag Care; 2003 Aug; 12(8):44-5. PubMed ID: 12966852
    [No Abstract]   [Full Text] [Related]  

  • 36. Photodynamic therapy: esophagus.
    Gossner L
    Can J Gastroenterol; 2002 Sep; 16(9):642-4. PubMed ID: 12362219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.
    Whitson MJ; Falk GW
    Gastroenterol Clin North Am; 2015 Jun; 44(2):299-315. PubMed ID: 26021196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is topical delta-aminolevulinic acid adequate for photodynamic therapy in Barrett's esophagus? A pilot study.
    Ortner M-; Zumbusch K; Liebetruth J; Ebert B; Fleige B; Dietel M; Lochs H
    Endoscopy; 2002 Aug; 34(8):611-6. PubMed ID: 12173080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening and surveillance for complications related to gastroesophageal reflux disease.
    Spechler SJ
    Am J Med; 2001 Dec; 111 Suppl 8A():130S-136S. PubMed ID: 11749938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of photodynamic therapy in the esophagus.
    Gross SA; Wolfsen HC
    Gastrointest Endosc Clin N Am; 2010 Jan; 20(1):35-53, vi. PubMed ID: 19951793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.